Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
Animals
Diet, High-Fat
Hepatocytes
/ drug effects
Humans
Hydrogen Sulfide
/ blood
Kelch-Like ECH-Associated Protein 1
/ metabolism
Lipoproteins, LDL
/ pharmacology
Liver
/ blood supply
Low Density Lipoprotein Receptor-Related Protein-1
/ metabolism
Male
Mice
Mice, Inbred C57BL
Morpholines
/ pharmacology
NF-E2-Related Factor 2
/ deficiency
Organothiophosphorus Compounds
/ pharmacology
Oxidative Stress
/ drug effects
Signal Transduction
/ drug effects
Streptozocin
Journal
Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
15
11
2019
revised:
02
03
2020
accepted:
14
03
2020
pubmed:
29
3
2020
medline:
22
6
2021
entrez:
29
3
2020
Statut:
ppublish
Résumé
Protein S-sulfhydration mediated by H We showed that in streptozotocin (STZ)-treated and high-fat diet (HFD)-treated low-density lipoprotein receptor-negative (LDLr H
Sections du résumé
BACKGROUND AND AIMS
Protein S-sulfhydration mediated by H
APPROACH AND RESULTS
We showed that in streptozotocin (STZ)-treated and high-fat diet (HFD)-treated low-density lipoprotein receptor-negative (LDLr
CONCLUSIONS
H
Substances chimiques
GYY 4137
0
Keap1 protein, mouse
0
Kelch-Like ECH-Associated Protein 1
0
Lipoproteins, LDL
0
Low Density Lipoprotein Receptor-Related Protein-1
0
Lrp1 protein, mouse
0
Morpholines
0
NF-E2-Related Factor 2
0
Nfe2l2 protein, mouse
0
Organothiophosphorus Compounds
0
Streptozocin
5W494URQ81
Hydrogen Sulfide
YY9FVM7NSN
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-302Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 by the American Association for the Study of Liver Diseases.
Références
Mowen KA, David M. Unconventional post-translational modifications in immunological signaling. Nat Immunol 2014;15:512-520.
Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, et al. H2S signals through protein S-sulfhydration. Sci Signal 2009;2:ra72.
Meng G, Zhao S, Xie L, Han Y, Ji Y. Protein S-sulfhydration by hydrogen sulfide in cardiovascular system. Br J Pharmacol 2018;175:1146-1156.
Wu DD, Wang DY, Li HM, Guo JC, Duan SF, Ji XY. Hydrogen sulfide as a novel regulatory factor in liver health and disease. Oxid Med Cell Longev 2019;2019:3831713.
Wang D, Ma Y, Li Z, Kang K, Sun X, Pan S, et al. The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice. Autophagy 2012;8:954-962.
Ci L, Yang X, Gu X, Li Q, Guo Y, Zhou Z, et al. Cystathionine gamma-Lyase deficiency exacerbates CCl4-induced acute hepatitis and fibrosis in the mouse liver. Antioxid Redox Signal 2017;27:133-149.
Chen LY, Chen Q, Zhu XJ, Kong DS, Wu L, Shao JJ, et al. Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism. Int Immunopharmacol 2016;36:23-30.
Li M, Xu C, Shi J, Ding J, Wan X, Chen D, et al. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut 2018;67:2169-2180.
Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, et al. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 2014;29:215-222.
Tell G, Vascotto C, Tiribelli C. Alterations in the redox state and liver damage: hints from the EASL Basic School of Hepatology. J Hepatol 2013;58:365-374.
Jadeja RN, Upadhyay KK, Devkar RV, Khurana S. Naturally occurring Nrf2 activators: potential in treatment of liver injury. Oxid Med Cell Longev 2016;2016:3453926.
Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov 2019;18:295-317.
Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 2018;98:1169-1203.
Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, et al. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 2013;18:1906-1919.
Xie L, Gu Y, Wen M, Zhao S, Wang W, Ma Y, et al. Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes 2016;65:3171-3184.
Liu Z, Han Y, Li L, Lu H, Meng G, Li X, et al. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(−/−) mice. Br J Pharmacol 2013;169:1795-1809.
Fan Z, Li L, Li M, Zhang X, Hao C, Yu L, et al. The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. Hepatology 2017;65:1904-1919.
Mani S, Cao W, Wu L, Wang R. Hydrogen sulfide and the liver. Nitric Oxide 2014;41:62-71.
Norris EJ, Feilen N, Nguyen NH, Culberson CR, Shin MC, Fish M, et al. Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2013;304:G1070-G1078.
Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005;19:1196-1198.
Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, et al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature 2018;562:600-614.
Eggler AL, Liu G, Pezzuto JM, van Breemen RB, Mesecar AD. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci U S A 2005;102:10070-10075.
Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 2018;556:113-117.
Guo C, Liang F, Shah Masood W, Yan X. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 S-sulfhydration, MAPK dependent anti-apoptosis and NF-kappaB dependent anti-inflammation pathway. Eur J Pharmacol 2014;725:70-78.
Huang P, Shen Z, Liu J, Huang Y, Chen S, Yu W, et al. Hydrogen sulfide inhibits high-salt diet-induced renal oxidative stress and kidney injury in Dahl rats. Oxid Med Cell Longev 2016;2016:2807490.
Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, et al. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 2008;28:2758-2770.
Kim S, Lee HG, Park SA, Kundu JK, Keum YS, Cha YN, et al. Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation. PLoS One 2014;9:e85984.
Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, et al. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther 2008;325:655-664.
Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, et al. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 2010;48:357-371.
Sugimoto H, Okada K, Shoda J, Warabi E, Ishige K, Ueda T, et al. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 2010;298:G283-G294.
Ramadori P, Drescher H, Erschfeld S, Schumacher F, Berger C, Fragoulis A, et al. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development. Free Radic Biol Med 2016;91:114-126.
Yu Z, Shao W, Chiang Y, Foltz W, Zhang Z, Ling W, et al. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia 2011;54:922-934.
Pi J, Leung L, Xue P, Wang W, Hou Y, Liu D, et al. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem 2010;285:9292-9300.
Chartoumpekis DV, Ziros PG, Psyrogiannis AI, Papavassiliou AG, Kyriazopoulou VE, Sykiotis GP, et al. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 2011;60:2465-2473.
Wang S, Zhu X, Xiong L, Ren J. Ablation of Akt2 prevents paraquat-induced myocardial mitochondrial injury and contractile dysfunction: role of Nrf2. Toxicol Lett 2017;269:1-14.
More VR, Xu J, Shimpi PC, Belgrave C, Luyendyk JP, Yamamoto M, et al. Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding. Free Radic Biol Med 2013;61:85-94.
Zhang Z, Zhou S, Jiang X, Wang YH, Li F, Wang YG, et al. The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome. Rev Endocr Metab Disord 2015;16:35-45.